Skip to main content

Month: January 2023

Sodexo Q1 Fiscal 2023: strong start to the year

Revenue growth +20.2% Organic revenue growth +12.3%Issy-les-Moulineaux, January 6, 2023 Sodexo (NYSE Euronext Paris FR 0000121220-OTC: SDXAY). Q1 Fiscal 2023 revenuesREVENUES(in millions of euros) Q1 FY23 Q1 FY22 ORGANIC GROWTH EXTERNAL GROWTH CURRENCY EFFECT TOTAL GROWTHNorth America 2,992 2,205         +15.7%         +1.1%         +18.8%         +35.7%Europe 2,047 2,023         +5.9%         -3.6%         -1.1%         +1.2%Rest of the World 1,057 854         +15.3%         -1.9%         +10.4%         +23.9%On-Site Services 6,097 5,082         +11.9%         -1.2%         +9.3%         +20.0%Benefits & Rewards Services 234 183         +23.4%         -1.6%         +6.4%         +28.2%Elimination (1) (1)        TOTAL GROUP 6,330 5,264         +12.3%         -1.2%         +9.2%         +20.2%Commenting...

Continue reading

Broad Capital Acquisition Corp Announces Postponement of Special Meeting of Shareholders Until January 10, 2023

Plano, Texas, Jan. 05, 2023 (GLOBE NEWSWIRE) — Broad Capital Acquisition Corp (the “Company”) (Nasdaq: BRAC/BRACU/BRACR), a special purpose acquisition company, today announced that it has postponed the Special Meeting of Shareholders scheduled to occur on January 9, 2023 (the “Special Meeting”) until January 10, 2023 at 10:30 am at the same location as set forth in the Proxy Statement. On December 28, 2022, the Company filed a Definitive Proxy Statement on Schedule 14A (the “Proxy Statement”) with the Securities and Exchange Commission (the “SEC”) with respect to the Special Meeting to vote on, among other things, a proposal to amend the Company’s Amended and Restated Certificate of Incorporation (the “Charter”) to extend the date by which the Company must consummate a business combination (the “Extension”) from January 13, 2022...

Continue reading

Celestica Q4 2022 Financial Results and Conference Call Thursday, January 26, 2023

TORONTO, Jan. 05, 2023 (GLOBE NEWSWIRE) — Celestica’s third quarter financial results and conference call will take place on Thursday, January 26. The conference call start time is 8:00am ET. Financial results will be released after market close on Wednesday, January 25. Participants are invited to join the live webcast at: https://viavid.webcasts.com/starthere.jsp?ei=1592033&tp_key=456f273f42 For those unable to participate, a recorded webcast will be available approximately two hours after completion of the call. To access the recorded webcast visit www.celestica.com. Contact Celestica Investor Relations(416) 448-2211clsir@celestica.com

Continue reading

AVEO Oncology Stockholders Approve Acquisition by LG Chem

BOSTON, Jan. 05, 2023 (GLOBE NEWSWIRE) — AVEO Oncology (“AVEO”) (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, announced that at a special meeting of stockholders (the “Special Meeting”) held today, AVEO stockholders approved the adoption of the Agreement and Plan of Merger among LG Chem, Ltd. (“LG Chem”), a subsidiary of LG Chem and AVEO (the “merger agreement”). As previously announced, under the terms of the merger agreement, AVEO stockholders will receive $15.00 per share in cash upon the closing of the transaction. “Today’s approval is a significant step toward the completion of AVEO’s transaction with LG Chem, and I thank our stockholders for their strong support,” said Michael Bailey, President and Chief...

Continue reading

BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030

Multi-year collaboration focuses on three strategic pillars: cancer immunotherapies, infectious disease vaccines, and expansion of BioNTech’s footprint in the UK BioNTech aims to design and roll out randomized clinical trials with registrational potential for the Company’s personalized mRNA cancer immunotherapies in the UK Accelerated clinical trial recruitment with first patient to be enrolled in a trial as part of this collaboration in H2 2023 Set-up of an R&D hub in Cambridge (UK) with the aim to employ more than 70 highly skilled scientists with the first employees commencing work in Q1 2023MAINZ, Germany, January 6, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech”, “the Company”) today announced that the Company signed a Memorandum of Understanding (“MoU”) with the Government of the United Kingdom (“UK”) to benefit patients by...

Continue reading

CTS Corporation to Participate at the 25th Annual Needham Growth Conference

LISLE, Ill., Jan. 05, 2023 (GLOBE NEWSWIRE) — CTS Corporation (NYSE: CTS) announced today that Kieran O’Sullivan, President and Chief Executive Officer, will be participating at the 25th Annual Needham Growth Conference on January 10, 2023, at 3:45 p.m. (EDT) in New York City. You may access a live webcast of the event using this link or from the Investors section of the CTS Corporation website at www.ctscorp.com. The webcast will also be available for replay on this website for 90 days following the presentation. About CTS CTS (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move. The company manufactures sensors, electronic components, and actuators in North America, Europe, and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical, and transportation...

Continue reading

KUORA INC. (Nevada) And ICON MEDIA HOLDINGS, INC (Nevada) – ACQUISITION TRANSACTION

Xi’an, China and Singapore, Jan. 05, 2023 (GLOBE NEWSWIRE) — Kuora Inc., formerly known as All American Pet Company, Inc (OTC: AAPT) (the “Company”, $AAPT), a Nevada Corporation, together with Icon Media Holdings, Inc., (OTC Pink: ICNM) (the “Company”, $ICNM), wish to make the following announcement:  Kuora Inc. has on December 26th 2022 entered into an Agreement with Eastwin8 Pte Ltd (Eastwin8), a Singapore subsidiary company 100% owned by Icon Media Holdings, Inc (ICNM) through which Eastwin8 will purchase 100% of the paid up capital of Kuora, Inc (China) (or Xi’an Xiaohuangren Industrial Interconnect Data Technology Limited), bearing enterprise registration number 91610103MA6UT0FW0R, (the “Kuora China Shares”), a China limited liability company (Xi’an Xiaohuangren) and all its subsidiary companies and associated companies) (collectively...

Continue reading

Emergent BioSolutions Awarded $379.6 Million Procurement Contract to Supply RSDL© (Reactive Skin Decontamination Lotion Kit) to U.S. Department of Defense

GAITHERSBURG, Md., Jan. 05, 2023 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed an indefinite-delivery, indefinite-quantity procurement contract with a maximum value up to $379.6 million to supply RSDL® (Reactive Skin Decontamination Lotion Kit) for use by all branches of the U.S. military. Emergent’s Canadian Subsidiary will serve as the sole subcontractor to deploy RSDL® to the U.S. Department of Defense (DoD) through a new contract award to the Canadian Commercial Corporation (CCC). The new contract has a base year, which began in December 2022, and four single year option renewals. “Emergent has a 25-year history of developing and supplying medical countermeasures (MCM) for the U.S. and other governments around the world,” said Paul Williams, senior vice president, government MCM...

Continue reading

StoneBridge Acquisition Corporation (NASDAQ: APAC) Announces Business Combination Agreement with Southeast Asia’s ‘Fintech-As-A-Service’ (FaaS) player – DigiAsia

DigiAsia is an Indonesia focussed Embeddable ‘Fintech-As-A-Service’ (FaaS) company, the combined company to be listed under the ticker symbol (Nasdaq: FAAS). Digi provides FaaS across Digital wallets, Utility Bill Payments, Banking-As-A-Service (BaaS), Supply Chain Payments, Remittances and Working Capital Loans to Merchants. Strong strategic partnerships validate investment potential. DigiAsia is the exclusive Mastercard partner in Indonesia and its other key partners include Western Union, Starbucks, Garuda Indonesia, Bukalapak, Semen Indonesia, KaiPay, eFishery, and Home Credit. The combined operating entity could have access to as much as $200 million in net cash upon deal close which will help fund DigiAsia’s growth by focusing on customer and ecosystem buildout, new BaaS product development, expansion with current customers, and...

Continue reading

AGF Management Limited to Release Fiscal 2022 Results on January 25, 2023

TORONTO, Jan. 05, 2023 (GLOBE NEWSWIRE) — AGF Management Limited (TSX: AGF.B) will release its financial results for fiscal 2022 on Wednesday, January 25, 2023 at approximately 8:00 a.m. ET. AGF will hold a conference call and webcast to discuss these results at 11:00 a.m. ET. The discussion will feature remarks by Kevin McCreadie, Chief Executive Officer and Chief Investment Officer, and Jenny Quinn, Vice-President and Interim Chief Financial Officer. Judy G. Goldring, President and Head of Global Distribution, will also be available for the question and answer period with investment analysts following the presentation. The live audio webcast with supporting materials will be available in the Investor Relations section of AGF’s website at www.agf.com or at https://edge.media-server.com/mmc/p/veoauyqt. Alternatively, the call can...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.